FDA Preparing To Endorse First-Ever HIV Prevention Drug
Doctors have used the Truvada HIV drug to treat HIV infected patients since it was approved for open market use in 2004 and now Food and Drug Administration (FDA) officials are preparing to clear the way for the drug to be the first HIV prevention option available on the open market.
After a series of votes an advisory panel this week recommended that the drug be approved for healthy people who are at a high risk of contracting HIV, specifically gay and bisexualmen and heterosexual couples in which one person is HIV-infected.
While the FDA is not required to follow the advisory panels suggestions it typically does. In any case a final decision is expected to be announced by June 15.
Truvada is already marketed by maker Gilead Sciences Inc., as a treatment for HIV infected people.
Comments
About the Author
James Johnson James is a new media professional with more than half a decade worth of experience in the online writing space. He currently serves as the Associate Editor of Inquisitr.com and the Editor-in-Chief of SocialNewsDaily.com. He also serves as a resident writer for Splash Press Media. In his spare time James consults businesses regarding SEO and Content Development.
Related Posts
Cow’s Milk To Contain HIV-Disabling Antibodies →
Artificial Pancreas Passes Feasibility Study – Very Successfully At That →
Could A Stem Cell Breakthrough Bring About A Possible Cure For AIDS? →
